Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
AbbVie to acquire Revolution Medicines soon
PUBLIC · ABBVJan 09, 2026•7 months ago
Acquiring Company
AbbVie Inc.
Acquired Company
Revolution Medicines, Inc.
North ChicagoRedwood CityManufacturingBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharmaBiotechnologyHealthcareHealth CareTherapeuticsPharmaceutical
Description
AbbVie is reportedly concluding acquisition talks with Revolution Medicines Inc., following a significant stock price surge of approximately 30%. The negotiations are expected to have a positive impact on shareholders, given Revolution Medicines' current valuation of around $16 billion. The acquisition talks are attracting attention from other pharmaceutical companies, including Merck, indicating high interest in Revolution Medicines' innovative offerings.
Company Information
Company
AbbVie Inc.
Location
1 North Waukegan Road
North Chicago, Illinois, United States
About
Venture capital subsidiary of Abbvie
Predictive Intelligence
Strategic
ML-powered predictions for AbbVie Inc.'s next move
North Chicago